+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Assisted Reproductive Technology Market Research Report by Type, by Diagnosis, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4904634
  • Report
  • July 2021
  • Region: Global
  • 192 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Assisted Reproductive Technology Market will Grow to USD 40.77 Billion by 2026, at a CAGR of 17.38%

FEATURED COMPANIES

  • Cook Medical Incorporated
  • CooperSurgical, Inc.
  • Esco Micro Pte. Ltd.
  • Merck & Co., Inc.
  • Nidacon International AB
  • OvaScience Inc.
The Global Assisted Reproductive Technology Market size was estimated at USD 15.58 Billion in 2020 and expected to reach USD 18.24 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 17.38% to reach USD 40.77 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Assisted Reproductive Technology to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the Assisted Reproductive Technology Market was studied across Artificial Insemination, Donor Conception, Gamete Intrafallopian Transfer, In-vitro Fertilization, Ovulation Induction, and Surrogacy.
  • Based on End User, the Assisted Reproductive Technology Market was studied across Clinics, Gynecology Centers, Hospitals, and IVF Centers.
  • Based on Diagnosis, the Assisted Reproductive Technology Market was studied across Genetic Testing, Hormone Testing, Hysterosalpingography, Imaging Testing, Ovarian Reserve Testing, and Ovulation Testing.
  • Based on Region, the Assisted Reproductive Technology Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Assisted Reproductive Technology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Assisted Reproductive Technology Market, including . Genea Limited, Cook Medical Incorporated, CooperSurgical, Inc., Esco Micro Pte. Ltd., FUJIFILM Irvine Scientific, Inc., Merck & Co., Inc., Nidacon International AB, OvaScience Inc., Planer PLC, and Vitrolife AB.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Assisted Reproductive Technology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Assisted Reproductive Technology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Assisted Reproductive Technology Market?
4. What is the competitive strategic window for opportunities in the Global Assisted Reproductive Technology Market?
5. What are the technology trends and regulatory frameworks in the Global Assisted Reproductive Technology Market?
6. What is the market share of the leading vendors in the Global Assisted Reproductive Technology Market?
7. What modes and strategic moves are considered suitable for entering the Global Assisted Reproductive Technology Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cook Medical Incorporated
  • CooperSurgical, Inc.
  • Esco Micro Pte. Ltd.
  • Merck & Co., Inc.
  • Nidacon International AB
  • OvaScience Inc.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. End User Outlook
3.5. Diagnosis Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing number of infertility cases due to stress, pollution, and obesity
5.1.1.2. Rising healthcare expenditure
5.1.1.3. Increasing prevalence of ovarian & endometrial cancer and PCOS issues
5.1.2. Restraints
5.1.2.1. High cost required for the procedure and lower success rate
5.1.3. Opportunities
5.1.3.1. Initiatives from government and public organizations increase awareness
5.1.3.2. Technological advancements to reduce the treatment complications
5.1.4. Challenges
5.1.4.1. Dearth of advanced infrastructure in developing economies
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Assisted Reproductive Technology Market, by Type
6.1. Introduction
6.2. Artificial Insemination
6.3. Donor Conception
6.4. Gamete Intrafallopian Transfer
6.5. In-vitro Fertilization
6.6. Ovulation Induction
6.7. Surrogacy

7. Assisted Reproductive Technology Market, by End User
7.1. Introduction
7.2. Clinics
7.3. Gynecology Centers
7.4. Hospitals
7.5. IVF Centers

8. Assisted Reproductive Technology Market, by Diagnosis
8.1. Introduction
8.2. Genetic Testing
8.3. Hormone Testing
8.4. Hysterosalpingography
8.5. Imaging Testing
8.6. Ovarian Reserve Testing
8.7. Ovulation Testing

9. Americas Assisted Reproductive Technology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Assisted Reproductive Technology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Assisted Reproductive Technology Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. . Genea Limited
13.2. Cook Medical Incorporated
13.3. CooperSurgical, Inc.
13.4. Esco Micro Pte. Ltd.
13.5. FUJIFILM Irvine Scientific, Inc.
13.6. Merck & Co., Inc.
13.7. Nidacon International AB
13.8. OvaScience Inc.
13.9. Planer PLC
13.10. Vitrolife AB

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2020 (USD BILLION)
FIGURE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2020 (USD BILLION)
FIGURE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2020 (USD BILLION)
FIGURE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2026
FIGURE 12. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2026 (USD BILLION)
FIGURE 13. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DONOR CONCEPTION, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DONOR CONCEPTION, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN-VITRO FERTILIZATION, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION INDUCTION, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION INDUCTION, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SURROGACY, 2018-2026 (USD BILLION)
FIGURE 23. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SURROGACY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 24. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 25. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2026
FIGURE 27. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CLINICS, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GYNECOLOGY CENTERS, 2018-2026 (USD BILLION)
FIGURE 30. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GYNECOLOGY CENTERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 31. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HOSPITALS, 2018-2026 (USD BILLION)
FIGURE 32. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 33. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IVF CENTERS, 2018-2026 (USD BILLION)
FIGURE 34. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IVF CENTERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 35. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2020 VS 2026 (%)
FIGURE 36. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2020 VS 2026 (USD BILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2026
FIGURE 38. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GENETIC TESTING, 2018-2026 (USD BILLION)
FIGURE 39. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GENETIC TESTING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 40. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HORMONE TESTING, 2018-2026 (USD BILLION)
FIGURE 41. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HORMONE TESTING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 42. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 43. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 44. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IMAGING TESTING, 2018-2026 (USD BILLION)
FIGURE 45. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IMAGING TESTING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 46. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVARIAN RESERVE TESTING, 2018-2026 (USD BILLION)
FIGURE 47. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVARIAN RESERVE TESTING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 48. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION TESTING, 2018-2026 (USD BILLION)
FIGURE 49. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION TESTING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 50. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 69. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 70. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 71. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 72. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 73. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 74. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 75. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 76. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 77. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 78. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 79. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: FPNV POSITIONING MATRIX
FIGURE 80. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DONOR CONCEPTION, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN-VITRO FERTILIZATION, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION INDUCTION, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SURROGACY, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GYNECOLOGY CENTERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IVF CENTERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HORMONE TESTING, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY REGION, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IMAGING TESTING, BY REGION, 2018-2026 (USD BILLION)
TABLE 21. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVARIAN RESERVE TESTING, BY REGION, 2018-2026 (USD BILLION)
TABLE 22. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2026 (USD BILLION)
TABLE 23. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 50. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 51. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 52. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: SCORES
TABLE 53. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: BUSINESS STRATEGY
TABLE 54. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: PRODUCT SATISFACTION
TABLE 55. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: RANKING
TABLE 56. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 57. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: MERGER & ACQUISITION
TABLE 58. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 59. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 60. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: INVESTMENT & FUNDING
TABLE 61. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 62. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • . Genea Limited
  • Cook Medical Incorporated
  • CooperSurgical, Inc.
  • Esco Micro Pte. Ltd.
  • FUJIFILM Irvine Scientific, Inc.
  • Merck & Co., Inc.
  • Nidacon International AB
  • OvaScience Inc.
  • Planer PLC
  • Vitrolife AB
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll